Outcomes of Patients tReated wIth Mitral Transcatheter Edge-to-edge Repair for Primary Mitral Regurgitation Registry

Status unconfirmed

Conditions studied: Mitral Regurgitation

In brief

This multinational, non-interventional, investigator-initiated, retrospective study aims to investigate outcomes of patients, who underwent mitral valve transcatheter edge-to-edge repair (M-TEER) for primary mitral regurgitation (PMR).

Key facts

Study ID

NCT05332782

Run by

Universitätsklinikum Hamburg-Eppendorf

People needed

2000

Starts

2022-03-01

Expected to finish

2026-01-01

Last updated by the study team

2022-04-18

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• clinically significant primary mitral regurgitation
• patient underwent M-TEER
• echocardiography data at baseline, procedure and follow-up
• follow-up of at least 12 months

You may not qualify if…

• age under 18 years

Where it is running

• Montefiore Medical Center — New York, New York, United States (enrolling)
• Centre Hospitalier de Bordeaux — Bordeaux, France (enrolling)
• Université Lille, Inserm, Centre Hospitalier Universitaire de Lille — Lille, France (enrolling)
• University Hospital of Rennes, Centre Hospitalier de Rennes — Rennes, France (enrolling)
• University Heart & Vascular Center Hamburg — Hamburg, Germany (enrolling)
• Klinikum der Universität München — Munich, Germany (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.